We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
LyondellBasell Grants Hostalen ACP License to Shandong Jinhai
Read MoreHide Full Article
LyondellBasell Industries N.V. (LYB - Free Report) has recently declared that Shandong Jinhai Chemical Co., Ltd. will use its Hostalen ‘Advanced Cascade Process’ (Hostalen ACP) technology for a new facility.
The Hostalen ACP is a low-pressure slurry process technology that manufactures high performance, multi-modal high-density polyethylene (HDPE) resins with increased toughness balance, high stress cracking resistance and impact resistance. The technology is used in pressure pipe, blow molding and film applications.
The technology will be used for a 400 kilo tons per annum (KTA) HDPE facility that will be built in Heze City, Shandong Province, P.R. China. With the latest capacity additions, LyondellBasell has now provided license to more than 8000 KTA of benchmark multi-modal HDPE resins.
The Shandong Jinhai facility will start operations using Avant Z509 and Avant Z501 catalysts to make a complete range of multi-modal HDPE products.
The new licensees are expected to benefit from LyondellBasell’s in-house expertise of continuous product and process improvement, which can be availed by optionally joining the company’s Technical Service program.
Shares of LyondellBasell have gained 7.8% in the past year against the industry’s 22.4% decline.
In November 2019, LyondellBasell stated that the company benefited from low-cost natural gas liquid feedstocks with favorable prices continuing into October 2019.
Moreover, LyondellBasell expects profitability at its Houston refinery to improve during the fourth quarter. Per the company, the upside is likely to be driven by an increase in demand for low-sulfur marine fuels ahead of the IMO 2020 regulation deadline.
Zacks Rank & Key Picks
LyondellBasell currently carries a Zacks Rank #3 (Hold).
Daqo New Energy has projected earnings growth rate of 315.4% for 2020. The company’s shares have skyrocketed 130.3% over a year.
Pan American Silver has an estimated earnings growth rate of 46.3% for 2020. Its shares have returned 51.1% in the past year.
Commercial Metals has an expected earnings growth rate of 17.3% for fiscal 2020. The company’s shares have rallied 43.2% in the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
LyondellBasell Grants Hostalen ACP License to Shandong Jinhai
LyondellBasell Industries N.V. (LYB - Free Report) has recently declared that Shandong Jinhai Chemical Co., Ltd. will use its Hostalen ‘Advanced Cascade Process’ (Hostalen ACP) technology for a new facility.
The Hostalen ACP is a low-pressure slurry process technology that manufactures high performance, multi-modal high-density polyethylene (HDPE) resins with increased toughness balance, high stress cracking resistance and impact resistance. The technology is used in pressure pipe, blow molding and film applications.
The technology will be used for a 400 kilo tons per annum (KTA) HDPE facility that will be built in Heze City, Shandong Province, P.R. China. With the latest capacity additions, LyondellBasell has now provided license to more than 8000 KTA of benchmark multi-modal HDPE resins.
The Shandong Jinhai facility will start operations using Avant Z509 and Avant Z501 catalysts to make a complete range of multi-modal HDPE products.
The new licensees are expected to benefit from LyondellBasell’s in-house expertise of continuous product and process improvement, which can be availed by optionally joining the company’s Technical Service program.
Shares of LyondellBasell have gained 7.8% in the past year against the industry’s 22.4% decline.
In November 2019, LyondellBasell stated that the company benefited from low-cost natural gas liquid feedstocks with favorable prices continuing into October 2019.
Moreover, LyondellBasell expects profitability at its Houston refinery to improve during the fourth quarter. Per the company, the upside is likely to be driven by an increase in demand for low-sulfur marine fuels ahead of the IMO 2020 regulation deadline.
Zacks Rank & Key Picks
LyondellBasell currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the basic materials space are Daqo New Energy Corp (DQ - Free Report) , Pan American Silver Corp (PAAS - Free Report) and Commercial Metals Company (CMC - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Daqo New Energy has projected earnings growth rate of 315.4% for 2020. The company’s shares have skyrocketed 130.3% over a year.
Pan American Silver has an estimated earnings growth rate of 46.3% for 2020. Its shares have returned 51.1% in the past year.
Commercial Metals has an expected earnings growth rate of 17.3% for fiscal 2020. The company’s shares have rallied 43.2% in the past year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>